These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22333366)

  • 1. Multi-group measurement invariance of the multiple sclerosis walking scale-12?
    Motl RW; Mullen S; McAuley E
    Neurol Res; 2012 Mar; 34(2):149-52. PubMed ID: 22333366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.
    Motl RW; McAuley E; Mullen S
    J Neurol Sci; 2011 Jun; 305(1-2):75-9. PubMed ID: 21474149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?
    Weikert M; Motl RW; Suh Y; McAuley E; Wynn D
    J Neurol Sci; 2010 Mar; 290(1-2):6-11. PubMed ID: 20060544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.
    Motl R; Neal W; Backus D; Hebert J; McCully K; Bethoux F; Plummer P; Ng A; Lowman J; Schmidt H; McBurney R; Cutter G
    BMC Neurol; 2024 Oct; 24(1):383. PubMed ID: 39390466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
    Marangoni BE; Pavan K; Tilbery CP
    Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobility, walking and physical activity in persons with multiple sclerosis.
    Kohn CG; Coleman CI; Michael White C; Sidovar MF; Sobieraj DM
    Curr Med Res Opin; 2014 Sep; 30(9):1857-62. PubMed ID: 24803286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
    Goldman MD; Ward MD; Motl RW; Jones DE; Pula JH; Cadavid D
    Mult Scler; 2017 Sep; 23(10):1405-1414. PubMed ID: 27903937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in self-reported walking ability in multiple sclerosis.
    Motl RW; Putzki N; Pilutti LA; Cadavid D
    PLoS One; 2015; 10(5):e0125002. PubMed ID: 25932911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
    Gijbels D; Alders G; Van Hoof E; Charlier C; Roelants M; Broekmans T; Eijnde BO; Feys P
    Mult Scler; 2010 May; 16(5):618-26. PubMed ID: 20207785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
    Snook EM; Motl RW; Gliottoni RC
    Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an 1-day education program on physical functioning, activity and quality of life in community living persons with multiple sclerosis.
    Feys P; Tytgat K; Gijbels D; De Groote L; Baert I; Van Asch P
    NeuroRehabilitation; 2013; 33(3):439-48. PubMed ID: 23949075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
    Learmonth YC; Motl RW; Sandroff BM; Pula JH; Cadavid D
    BMC Neurol; 2013 Apr; 13():37. PubMed ID: 23617555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
    Agiovlasitis S; Sandroff BM; Motl RW
    J Rehabil Res Dev; 2016; 53(2):199-206. PubMed ID: 27148824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis Walking Scale-12 and oxygen cost of walking.
    Motl RW; Dlugonski D; Suh Y; Weikert M; Agiovlasitis S; Fernhall B; Goldman M
    Gait Posture; 2010 Apr; 31(4):506-10. PubMed ID: 20226676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.